DrugPatentWatch Database Preview
Biocryst Company Profile
What is the competitive landscape for BIOCRYST, and what generic alternatives to BIOCRYST drugs are available?
BIOCRYST has one approved drug.
There are three US patents protecting BIOCRYST drugs.
Summary for Biocryst
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Biocryst
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | RX | Yes | Yes | 6,503,745 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Biocryst Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| South Africa | 9811595 | ➤ Sign Up |
| Japan | 2008163035 | ➤ Sign Up |
| Japan | 5118502 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
